MCNULTY JAMES A 4
4 · Inhibitor Therapeutics, Inc. · Filed May 17, 2023
Insider Transaction Report
Form 4
MCNULTY JAMES A
Chief Financial Officer
Transactions
- Other
Common Stock
2023-05-05+398,135→ 946,135 total - Other
Common Stock
2023-05-05−79,627,069→ 0 total(indirect: See footnote) - Other
Common Stock
2023-05-05+20,101,057→ 26,101,057 total(indirect: See footnote)
Footnotes (2)
- [F1]Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC.
- [F2]Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares.